Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PON2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
UBE2V2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC46A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGEF6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXW2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GFRA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
XPOT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAF9B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EIF4EBP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CEP78 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NFIA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STIM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
REEP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHML - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SIAE - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FOXN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DIAPH3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NEB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AIF1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on